Efficacy of antidepressants for depression in Alzheimer's disease: systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Depression is common in people with Alzheimer's disease (AD) affecting overall outcomes and decreasing quality of life. Although depression in AD is primarily treated with antidepressants, there are few randomized controlled trials (RCTs) assessing efficacy and results have been conflicting. OBJECTIVES: To systematically review evidence on efficacy of antidepressant treatments for depression in AD. METHODS: Systematic review and meta-analysis of double blind RCTs comparing antidepressants versus placebo for depression in AD. We searched MEDLINE, CINAHL, EMBASE, PsycINFO, the Cochrane Controlled Trials Register and on line national and international registers. Primary outcomes were treatment response and depressive symptoms. Secondary outcomes were cognition, acceptability, and tolerability. Risk of bias was also assessed. RESULTS: Seven studies met inclusion criteria. Three compared sertraline with placebo; one compared both sertraline and mirtazapine to placebo; imipramine, fluoxetine, and clomipramine were evaluated in one study each. In terms of response to treatment (6 studies, 297 patients treated with antidepressants and 223 with placebo), no statistically significant difference between antidepressants and placebo was found (odds ratio (OR) 1.95, 95% CI 0.97-3.92). We found no significant drug-placebo difference for depressive symptoms (5 studies, 311 patients, SMD -0.13; 95% CI -0.49 to 0.24). Overall quality of the evidence was moderate because of methodological limitations in studies and the small number of trials. CONCLUSION: Despite the importance of depression in people with AD, few RCTs are available on efficacy of antidepressants, limiting clear conclusions of their potential role. There is a need for further high quality RCTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Limited information is available on the efficacy of antidepressants amongst older people with cognitive impairment and dementia (Boyce 2012;Nelson 2011;Orgeta 2017), which is problematic given the high prevalence of these conditions in the LTC population.”
From Psychological therapies for depression in older adults residing in long-term care settings (2024) · cites this paper as Orgeta 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neuropsychiatric symptoms are common and often clustered in people with dementia.”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [210]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Patients suffering from AD are more prone to comorbid depression [40, 41]”
From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [41]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These symptoms might precede dementia and are associated with tau and amyloid neuropathology.210”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [210]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“We used the GRADE approach [41] to summarize overall quality of evidence.”
MethodCognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Mapelli, D., Di Rosa, E., Nocita, R., & Sava, D. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353457 · Cited by 3,453
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247 · cited 1×
“cognitive impairment is the hallmark of the illness, neuropsychiatric symptoms affect almost all patients and are persistent [3, 4].”
BackgroundPredictors of nursing home admission for persons with dementia
Gaugler, J. E., Yu, F., Krichbaum, K., & Wyman, J. F. (2009) · Medical Care · doi:10.1097/mlr.0b013e31818457ce · Cited by 617
Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial
Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., et al. (2014) · JAMA · doi:10.1001/jama.2014.93 · Cited by 572
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398 · cited 2×
“Three studies compared sertraline with placebo [19, 21, 46], one RCT compared both sertraline and mirtazapine to placebo [47]; imipramine [20], fluoxetine [22], and clomipramine [18] were examined in one study each.”
BackgroundResult
Research works printed but not linked: 1
- Knapp M, Comas-Herrera A, Wittenberg R, Hu B, King D, Rehill A, Adelaja B (2014) Scenarios of dementia care: What are the impacts on cost and quality of life? PSSRU Discussion Paper, 2878, Personal Social Services Research Unit, London, UK.
Cited by
Items 101–200 of 213
Effectiveness of creative story therapy for dementia: a systematic review and meta-analysis
Ma, J., Wang, Q., Lang, Y., Lv, S., Xu, Y., & Wei, B. (2023) · European journal of medical research · doi:10.1186/s40001-023-01337-7 · Cited by 10
Pharmacologic treatment of depression in Alzheimer’s disease
Haußmann, R., & Donix, M. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000439 · Cited by 10
Association between napping and cognitive impairment: A systematic review and meta-analysis
Fang, W., Shi, L., Wang, H., Peng-Jiao, X., Shuai, Y., Rui-Ling, Z., Lü, L., & Yahui, X. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.09.022 · Cited by 11
Jin, B., Xv, Y., Zhang, B., Qiao, L., & Liu, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1037414 · Cited by 9
Rangseekajee, P., Aphisitphinyo, S., Paholpak, P., Piyavhatkul, N., Vadhanavikkit, P., Kaenampornpan, M., & Paholpak, P. (2021) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14164 · Cited by 9
Depression and antidepressant prescribing in the elderly
Herron, J. W., & Mitchell, A. (2018) · Prescriber · doi:10.1002/psb.1654 · Cited by 9
Hvidsten, L., Engedal, K., Selbæk, G., Wyller, T. B., Benth, J. Š., & Kersten, H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-199007 · Cited by 9
O’Sullivan, J. L., Schweighart, R., Lech, S., Kessler, E., Tegeler, C., Teti, A., Nordheim, J., & Gellert, P. R. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03876-5 · Cited by 9
Hølmkjær, P., Rozing, M. P., Overbeck, G., Siersma, V., & Holm, A. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02894-y · Cited by 8
GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia
Vattathil, S., Blostein, F., Miller‐Fleming, T. W., Davis, L. K., Initiative, A. D. N., Wingo, T. S., & Wingo, A. P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70329 · Cited by 8
Jin, X., Xu, C.-Y., Fei, J.-F., Fang, Y., & Sun, C.-H. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i8.1216 · Cited by 7
Mario, A., Leccisotti, I., Claudia, M. M., Bellomo, A., Panza, F., Tommaso, C., & Madia, L. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118199 · Cited by 9
L’utilisation des antidépresseurs dans l’épisode dépressif caractérisé unipolaire du sujet âgé
Péricaud, A., Straczek, C., Montastruc, F., Leboyer, M., Yrondi, A., & Arbus, C. (2022) · L Encéphale · doi:10.1016/j.encep.2021.11.006 · Cited by 10
Towards Defining the Neuroanatomical Basis of Late-Onset Psychiatric Symptoms
Barker, M. S., Cosentino, S., Fremont, R., Devanand, D. P., & Huey, E. D. (2022) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887221090213 · Cited by 7
Lin, J. T., Morisaki, M., Sampathkumar, S. A., Lau, L. C., Boche, D., Khandaker, G. M., & Sinclair, L. I. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104051 · Cited by 6
Jawharieh, H., Tabbaa, L., Ang, C. S., Cheung, E. T. H., & Covaci, A. (2024) · International Journal of Human-Computer Interaction · doi:10.1080/10447318.2024.2400400 · Cited by 8
González-Gutiérrez, J. P., Castillo-Ríos, D., Ríos-Campos, V., González-Gutiérrez, I. A., Melivilu, D. F., Hormazábal, E., Moraga-Nicolás, F., Segura, K., Hernández, V., Farías-Cea, A., et al. (2025) · Molecules · doi:10.3390/molecules30143047 · Cited by 6
Treating Depression in Dementia Patients: A Risk or Remedy—A Narrative Review
Sultan, S. (2024) · Geriatrics · doi:10.3390/geriatrics9030064 · Cited by 6
Translation and Validation of 10/66 Dementia Diagnostic Battery in Urdu in Karachi, Pakistan
Khan, Q. U. A., Prince, M. J., Khalid, W., & Zulfiqar, M. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000359 · Cited by 6
What are we trying to prevent in Alzheimer disease?
Jessen, F. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/fjessen · Cited by 7
The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer’s disease
Rao, J. S., Tangarife, M. A., Venegas, M., Forero, B., Tamayo, L. L. G., Escobar-Gallego, J. P., Rodríguez‐Soacha, D. A., Ferreirós, A., & Mukunda, R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1709266 · Cited by 5
García‐Alberca, J. M., de la Guía, P., Gris, E., Mendoza, S., de la Rica, M. L., Barbancho, M. Á., Lara, J. P., & Blanco‐Reina, E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090918 · Cited by 7
Moon, C., Zhang, M., Wang, B., Gardner, S. E., Geerling, J. C., & Hoth, K. F. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.105846 · Cited by 5
Bhattacharjee, S., Lee, J. K., Vadiei, N., Patanwala, A. E., Malone, D. C., Knapp, S. M., Lo‐Ciganic, W., & Burke, W. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s241749 · Cited by 8
Bergmann, C., Stögmann, E., & Lehrner, J. P. (2021) · Brain Disorders · doi:10.1016/j.dscb.2021.100014 · Cited by 5
Wright, A. L., Weible, A. P., Estes, O. B., & Wehr, M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1505908 · Cited by 4
Davis, M. P. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_102-1 · Cited by 5
Syndrome-Based Prescription to Optimize Psychotropics: Are CHROME Criteria a Game Changer?
Múñiz, R., López‐Álvarez, J., Agüera-Ortíz, L., Perea, L., & Olazarán, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.662228 · Cited by 4
Amine Precursors in Depressive Disorders and the Blood-Brain Barrier
Sharma, H. S., & Sharma, A. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_423-1 · Cited by 4
Regen, F., & Benkert, O. (2018) · Springer eBooks · doi:10.1007/978-3-662-57334-1_1 · Cited by 5
Yoon, K. H., Moon, Y. S., & Kim, D. H. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00433-6 · Cited by 4
Gitlin-Leigh, G., Wilson, J., Howard, R., Howard, R. J., & Costello, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378156 · Cited by 3
Self-citationMitterwallner, M., Radjenovic, S., Grigoryeva, D., Bender, L., Gaal, M., Osou, S., Zettl, A., Plischek, N., Lachmair, P., Herzhauser, K., et al. (2026) · Psychological Medicine · doi:10.1017/s0033291726103274 · Cited by 3
Heybe, M. A., Verma, S., Moyano, B. P., Stewart, R. J., Mueller, C., & Davis, K. A. S. (2026) · Age and Ageing · doi:10.1093/ageing/afag221 · Cited by 3
Symptomatic treatment for Alzheimer disease: current evidence and future directions
Ballard, C. G., Doherty, P., Ismail, Z., Corbett, A., & Cummings, J. L. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01260-5 · Cited by 3
Yang, T., Guo, Z., Li, J., Zhu, H., Cao, Y., Ding, Y., & Liu, X. (2024) · Biological Psychology · doi:10.1016/j.biopsycho.2024.108785 · Cited by 3
Tuijt, R., Livingston, G., Gould, R. L., Jones, R., Verdaguer, E. S., & Orgeta, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021074 · Cited by 4
Self-citationDepression and somatic symptoms in dementia: A narrative review
Mukku, S. S. R., Desai, G., & Chaturvedi, S. K. (2020) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_4_20 · Cited by 4
Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
Mess, E., Witkowicz, M., Ornat, M., Sielski, P., & Klaszczyk, T. (2018) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2018.03.008 · Cited by 3
Mental Health Interventions for the Elderly
Mikesell, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-12852-4_8-1 · Cited by 3
da Silva, A. M. P., Falcão, L., Ribeiro, F. V., Donato, K. O., Magalhães, P., Nascimento, M. D. V. S., Leite, M. G. H. S. J., Han, M. L., Quiroga, D. G., Franco, E. D. S., et al. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251369893 · Cited by 3
Antidepressant Use Among US Nursing Home Residents With Dementia
Liang, S., Lapane, K. L., Ott, B. R., Tjia, J., Baek, J., Yuan, Y., & Alcusky, M. J. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70492 · Cited by 2
Li, W., Wei, Z.-W., & Liu, X. (2020) · Medicine · doi:10.1097/md.0000000000023076 · Cited by 3
Brucki, S. M. D., Aprahamian, I., Borelli, W. V., Calil, V., Ferretti‐Rebustini, R. E. D. L., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., Frota, N. A. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s107en · Cited by 3
Wang, B., Cui, C., Chen, Y., & Liang, Z. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1328143 · Cited by 2
Pharmacology of Psychiatric and Neurologic Drugs
Robbins, M. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-53954-1_7 · Cited by 2
Mansouri, Z., Khodagholi, F., Zaringhalam, J., Abbaszadeh, F., Ghasemi, R., & Maghsoudi, N. (2024) · EXCLI journal · doi:10.17179/excli2023-6818 · Cited by 3
Effects of Multi-Sensory Stimulation on Apathy Symptoms in Elderly Patients with Alzheimer's Disease
Li, Y., Zhao, T., Wang, Y., Xuewen, Y., Lv, Y., Li, S., Yang, X., & Li, L. (2024) · Iranian Journal of Public Health · doi:10.18502/ijph.v53i6.15908 · Cited by 7
Christofi, I., Ploutarchou, G., Savva, C., & Karagiannis, C. (2024) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2024.10.028 · Cited by 2
What is the evidence for using antidepressants to reduce anxiety for people with dementia?
Bingley, J., Young, A., & Chong, T. W. H. (2024) · Archives of Gerontology and Geriatrics Plus · doi:10.1016/j.aggp.2024.100108 · Cited by 3
Amin, S., Qusti, S. Y., Al‐Otaibi, W. A., AlMotwaa, S. M., Albogamy, N. T. S., Al‐Seeni, M. N., Alshammari, E. M., Babaker, M. A., & Saeed, A. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04443-6 · Cited by 2
Lange‐Asschenfeldt, C., & Benkert, O. (2020) · Springer eBooks · doi:10.1007/978-3-662-61753-3_6 · Cited by 3
Aga, V. M., Shad, M. U., Zhu, H., & Salzman, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00023-5 · Cited by 3
Paradise, M. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.010 · Cited by 2
Neuropsychiatric symptoms in Alzheimer’s disease
Vegytė, J., Podėnė, R., Dlugauskas, E., & Vaitkevičius, A. (2024) · Neurologijos seminarai · doi:10.29014/ns.2023.27.10 · Cited by 1
Antidepressant use in dementia: Assessing effective strategies for a vulnerable population
Cozza, M., Fimognari, F. L., Castagna, A., & Boccardi, V. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106340 · Cited by 1
Siwek, A., Marcinkowska, M., Mordyl, B., Głuch‐Lutwin, M., Wolak, M., Jastrzębska‐Więsek, M., Wilczyńska-Zawal, N., Wyska, E., Szafrańska, K., Wesołowska, A., et al. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174128 · Cited by 1
Depression in neurologic disorders, incidence and its treatment
Racková, S. (2018) · Neurologie pro praxi · doi:10.36290/neu.2018.147 · Cited by 1
Pharmacologic Management of Patients with Neurologic Disorders
Robbins, M. R. (2019) · Springer eBooks · doi:10.1007/978-3-319-99852-7_7 · Cited by 2
Tratamiento de los síntomas conductuales y psicológicos de las demencias con antidepresivos
Rodríguez, O. W. M. A. A. S., & Cameselle, L. R. (2019) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2019.03.002 · Cited by 1
Sex differences in psychiatric disorders and their implication for dementia
Biskup, E. M., Jordan, V., Nasta, B., & Rauen, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00005-3 · Cited by 2
Neuropharmacology of Dementias
Ransmayr, G. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_259 · Cited by 1
Behavioural and Psychological Symptoms of Dementia in Hospital Settings
Hayer, R. K., & Tadros, G. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108292252.011 · Cited by 2
Fakih, N., & Fakhoury, M. (2024) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000779 · Cited by 1
SSRIs and Alzheimer’s Disease: A Complex Relationship
Enayat, P., Norouzizadeh, F., Bahrami, M., Saberi, S., Solhirad, M., & Karimi‐Zandi, L. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00309-x · Cited by 1
Caregivers of Parents with Alzheimer's Disease
Cornu, M. (2019) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2019.377 · Cited by 1
Vattathil, S., Duong, D. M., Gearing, M., Seyfried, N. T., Wilson, R. S., Bennett, D. A., Woltjer, R. L., Wingo, T. S., & Wingo, A. P. (2026) · medRxiv · doi:10.64898/2026.04.23.26351110 · Cited by 1
Lange‐Asschenfeldt, C. (2018) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-018-2634-6
Management of Alzheimer's disease
Rainer, M. K., & Mucke, H. A. (2019) · Hamdan Medical Journal · doi:10.4103/hmj.hmj_10_19
The Potential Drug-Drug Interactions in Alzheimer Patients’ Treatment
Savran, M., Aşçı, H., Şengeze, N., Önal, Ö., & Demirci, S. (2019) · Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi · doi:10.22312/sdusbed.599102 · Cited by 1
Brelsford, A. R. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Psychotropic Drug Treatment in Later Life
Davies, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.020 · Cited by 1
Cebulak, A. (2017) · UND Scholarly Commons (University of North Dakota)
Neuropharmacology of Dementias
Ransmayr, G. N. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_259-1
Morsiani, A. (2011) · Cineforum
Haj, M. E., Boutoleau‐Bretonnière, C., Gallouj, K., Allain, P., & Antoine, P. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2021.2023811
Supportive Pharmacological Treatment
Otoni, K. M., MORMINO, K. B. N. T., dos Santos, S. L. F., & Pereira, M. L. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-94383-7_6
Ford, A. H., & Almeida, O. P. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108593946.013
Jessen, F. (2021) · J.B. Metzler eBooks · doi:10.1007/978-3-476-05352-7_22 · Cited by 1
Stengren, T. (2021) · ISU Red - Research and eData (Illinois State University) · doi:10.30707/etd2022.20221020070314670537.999965 · Cited by 1
The consequences of depression in Alzheimer's: A Literature Review
Santos, M. P., Mansur, M. P. C. R., Beraldo, D. F. G. D. C. G. H. V. V. C. A. L. B. R. C. J. M. F. C. S. L. C. C. S., Araújo, R. A., Vieira, G. H., & Loyola, A. B. A. T. (2022) · International Journal of Health Science · doi:10.22533/at.ed.1592772202123
Amine Precursors in Depressive Disorders and the Blood-Brain Barrier
Sharma, H. S., & Sharma, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_423
Analysis of Comorbidities between Depression and Alzheimer’s Disease and Intervention Methods
殷, 婷. (2022) · Advances in Psychology · doi:10.12677/ap.2022.1211447
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_102
Efectos del tratamiento antidepresivo en la cognición de pacientes con enfermedad de Alzheimer
García-Alberca, J. M. (2023) · Kranion · doi:10.24875/kranion.m23000048 · Cited by 1
Komorbiditäten bei Alzheimer-Demenz
Untersteiner, H., & Stögmann, E. (2023) · psychopraxis neuropraxis · doi:10.1007/s00739-023-00910-3
Lange‐Asschenfeldt, C., & Benkert, O. (2023) · Springer eBooks · doi:10.1007/978-3-662-67685-1_6
Zhang, Y., Zhao, H., Yi, J., Kurban, N., Cui, S., Chen, X., Hu, X., Zhang, Y., Yu, Q., & Zhang, Y. (2023) · Progress in Neurobiology · doi:10.60124/j.pneuro.2023.30.05
Efficacy of Antidepressants in the Treatment of Depression Associated with Alzheimer’s Dementia
Rusu, R., Nicoară, R.-D., & Coman, H. G. (2025) · BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE · doi:10.70594/brain/16.2/3
The paradoxical protective effect of chronic stress on advanced Alzheimer's disease pathology.
Shor, Y., Said, R., Fainstein, N., Wolf, G., Stepanov, L. S., Lachish, M., Ganz, T., Shwaiky, Y., Benyamini, H., Nevo, Y., et al. (2025) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2025.106224
Ma, J., Wang, Q., Lang, Y., Lv, S., Xu, Y., & Wei, B. (2024) · Figshare · doi:10.6084/m9.figshare.26617264
Ma, J., Wang, Q., Lang, Y., Lv, S., Xu, Y., & Wei, B. (2024) · Figshare · doi:10.6084/m9.figshare.26617261
Affleck, A. J. (2023) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/24899
Ma, J., Wang, Q., Lang, Y., Lv, S., Xu, Y., & Wei, B. (2024) · Figshare · doi:10.6084/m9.figshare.26617267
Jessen, F. (2026) · Springer eBooks · doi:10.1007/978-3-476-06005-1_22-1
Bhatia, P., Rosales, J. P., Patel, P., Brini, G., Singh, J., Patel, R., Petroski, J., Brisman, B., Sandhu, M., Santacroce, N., et al. (2026) · Cureus · doi:10.7759/cureus.104771
Metadata
- Authors
- Orgeta, V., Tabet, N., Nilforooshan, R., & Howard, R.
- Affiliations
- Brighton and Sussex Medical School (GB)
- Corresponding author
- Orgeta, Vasiliki
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2017-06-05
- Volume
- 58
- Issue
- 3
- Pages
- 725-733
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5467718
- OpenAlex
- W2612913686
- Cited by
- 203
- References
- 50
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 29 · 2023: 23 · 2022: 30 · 2021: 30 · 2020: 18 · 2019: 25 · 2018: 15
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by-nc)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc)
- Funders
- Alzheimer's Society
- National Institute for Health and Care Research
- University College London
- University College London Hospitals NHS Foundation Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, depression
- MeSH terms
- Alzheimer Disease, Antidepressive Agents, Depressive Disorder, Humans, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.